— Know what they know.
Not Investment Advice

CHEK

Check-Cap Ltd.
1W: -1.7% 1M: +13.4% 3M: -21.9% 1Y: +189.4% 3Y: -41.2% 5Y: -73.8%
$1.68
Last traded 2025-12-18 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $9.8M
Smart Money Score
No convergence signal
Key Statistics
Market Cap$9.8M
52W Range0.56-3.13
Volume365,085
Avg Volume3,038,154
Beta0.46
Dividend
Analyst Ratings
4 Buy 2 Hold 0 Sell
Consensus Buy
Company Info
CEODavid Lontini
Employees85
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2015-03-04
Check-Cap Building
Isfiya 30090
IL
972 4 830 3401
About Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms